Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/241980 
Authors: 
Year of Publication: 
2020
Citation: 
[Journal:] International Journal of Quality Innovation [ISSN:] 2363-7021 [Volume:] 6 [Issue:] 1 [Publisher:] Springer [Place:] Heidelberg [Year:] 2020 [Pages:] 1-10
Publisher: 
Springer, Heidelberg
Abstract: 
Benign prostatic hyperplasia (BPH) and chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) are common chronic diseases. None of the available treatments are effective in the management of these diseases. The purpose of this study was to assess the efficacy of Thermobalancing therapy (TT) with therapeutic Dr Allen's Device (DATD) for the treatment of BPH and CP/CPPS. Retrospective analysis of 2 clinical studies employing 6-month TT for the treatment of BPH (n = 124) and CP/ CPPS (n = 45) was conducted. The efficacy of the TT with DATD was assessed using validated and widely accepted parameters. Results were compared with corresponding control groups comprising of subjects who did not receive any treatment. In BPH treatment group, urinary symptoms decreased (14.3 to 4.7) and QoL improved (3.9 to 1.39). In CP/CPPS treatment group, pain score decreased (10.3 to 3.5) and QoL improved (8.1 to 2.9). The results in the 2 treatment groups were statistically significantly better than the results obtained for the corresponding control groups (P < 0.001). Innovative TT with DATD provides an effective treatment that uniquely employs body energy for the management of BPH and CP/CPPS.
Subjects: 
Chronic pelvic pain
Benign prostatic hyperplasia (BPH)
Chronic prostatitis
Thermobalancing therapy and Dr Allen's Device
Body energy
Persistent Identifier of the first edition: 
Creative Commons License: 
cc-by Logo
Document Type: 
Article

Files in This Item:
File
Size
684.61 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.